Cite
HARVARD Citation
Board, R. et al. (2021). Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018. International journal of cancer. 148 (4), pp. 868-875. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Board, R. et al. (2021). Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018. International journal of cancer. 148 (4), pp. 868-875. [Online].